Chronic Spontaneous Urticaria. Etiology and Pathogenesis

Immunology and Allergy Clinics of North America

Volumn 34, Issue 1, 2014, Pages 33-52

  Saini, Sarbjit S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basophils; Chronic urticaria; Mast cells

Indexed keywords

AUTOANTIBODY;

AQUAGENIC URTICARIA; AUTOIMMUNITY; BASOPHIL; CHOLINERGIC URTICARIA; CHRONIC SPONTANEOUS URTICARIA; CHRONIC URTICARIA; CLINICAL FEATURE; COLD CONTACT URTICARIA; CRYOGLOBULINEMIA; CRYOPYRIN MEDIATED PERIODIC SYNDROME; DELAYED PRESSURE URTICARIA; DERMOGRAPHISM; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; FOOD ALLERGY; HEAT CONTACT URTICARIA; HUMAN; HYPEREOSINOPHILIC SYNDROME; INFECTION; MALIGNANT NEOPLASTIC DISEASE; MAST CELL; PATHOGENESIS; PHYSICAL URTICARIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SCHNITZLER SYNDROME; SOLAR URTICARIA; SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; URTICARIAL VASCULITIS; VIBRATORY URTICARIA;

BASOPHILS; CHRONIC URTICARIA; MAST CELLS;

AUTOIMMUNITY; CHRONIC DISEASE; HUMANS; PROGNOSIS; RISK FACTORS; URTICARIA;

EID: 84888011027     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2013.09.012     Document Type: Review

References (121)

1. Greaves M.W. Chronic urticaria. NEngl J Med 1995, 332(26):1767-1772.
2. Grattan C.E., Sabroe R.A., Greaves M.W. Chronic urticaria. JAm Acad Dermatol 2002, 46(5):645-657.
3. Magerl M., Borzova E., Gimenez-Arnau A., et al. The definition and diagnostic testing of physical and cholinergic urticarias-EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy 2009, 64(12):1715-1721. 10.1111/j.1398-9995.2009.02177.x.
4. Zuberbier T., Asero R., Bindslev-Jensen C., et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009, 64(10):1417-1426. 10.1111/j.1398-9995.2009.02179.x.
5. Kaplan A.P. Chronic urticaria: pathogenesis and treatment. JAllergy Clin Immunol 2004, 114(3):465-474.
6. Sabroe R.A., Seed P.T., Francis D.M., et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. JAm Acad Dermatol 1999, 40(3):443-450.
7. Kaplan A.P., Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy 2009, 39(6):777-787. 10.1111/j.1365-2222.2009.03256.x.
8. Frigas E., Park M.A. Acute urticaria and angioedema: diagnostic and treatment considerations. Am J Clin Dermatol 2009, 10(4):239-250. 10.2165/00128071-200910040-00004.
9. Greaves M. Chronic urticaria. JAllergy Clin Immunol 2000, 105(4):664-672.
10. Gaig P., Olona M., Munoz Lejarazu D., et al. Epidemiology of urticaria in Spain. JInvestig Allergol Clin Immunol 2004, 14(3):214-220.
11. Zuberbier T., Balke M., Worm M., et al. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol 2010, 35(8):869-873. 10.1111/j.1365-2230.2010.03840.x.
12. Cooper K.D. Urticaria and angioedema: diagnosis and evaluation. JAm Acad Dermatol 1991, 25(1 Pt 2):166-174.
13. Champion R.H., Roberts S.O., Carpenter R.G., et al. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969, 81(8):588-597.
14. Najib U., Bajwa Z.H., Ostro M.G., et al. Aretrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2009, 103(6):496-501. 10.1016/S1081-1206(10)60266-9.
15. Ferrer M. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. Alergologica 2005. JInvestig Allergol Clin Immunol 2009, 19(Suppl 2):21-26.
16. Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 1981, 104(4):369-381.
17. Buss Y.A., Garrelfs U.C., Sticherling M. Chronic urticaria-which clinical parameters are pathogenetically relevant? A retrospective investigation of 339 patients. JDtsch Dermatol Ges 2007, 5(1):22-29. 10.1111/j.1610-0387.2007.06194.x.
18. Zazzali J.L., Broder M.S., Chang E., et al. Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2012, 108(2):98-102. 10.1016/j.anai.2011.10.018.
19. Nebiolo F., Bergia R., Bommarito L., et al. Effect of arterial hypertension on chronic urticaria duration. Ann Allergy Asthma Immunol 2009, 103(5):407-410. 10.1016/S1081-1206(10)60360-2.
20. Kulthanan K., Jiamton S., Thumpimukvatana N., et al. Chronic idiopathic urticaria: prevalence and clinical course. JDermatol 2007, 34(5):294-301. 10.1111/j.1346-8138.2007.00276.x.
21. Kozel M.M., Bossuyt P.M., Mekkes J.R., et al. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. JAm Acad Dermatol 2003, 48(3):409-416. 10.1067/mjd.2003.142.
22. Kulp-Shorten C.L., Callen J.P. Urticaria, angioedema, and rheumatologic disease. Rheum Dis Clin North Am 1996, 22(1):95-115.
23. Toubi E., Kessel A., Avshovich N., et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004, 59(8):869-873.
24. Leznoff A., Josse R.G., Denburg J., et al. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983, 119(8):636-640.
25. Confino-Cohen R., Chodick G., Shalev V., et al. Chronic urticaria and autoimmunity: associations found in a large population study. JAllergy Clin Immunol 2012, 129(5):1307-1313. 10.1016/j.jaci.2012.01.043.
26. Dreskin S.C., Andrews K.Y. The thyroid and urticaria. Curr Opin Allergy Clin Immunol 2005, 5(5):408-412.
27. Kikuchi Y., Fann T., Kaplan A.P. Antithyroid antibodies in chronic urticaria and angioedema. JAllergy Clin Immunol 2003, 112(1):218.
28. Sheikh J., Saini S.S., Kulczycki A., et al. Asurvey of allergists regarding the association of thyroid autoimmunity with chronic urticaria. JAllergy Clin Immunol 2009, 123(5):1173-1175. 10.1016/j.jaci.2008.12.1130.
29. Lindelof B., Sigurgeirsson B., Wahlgren C.F., et al. Chronic urticaria and cancer: an epidemiological study of 1155 patients. Br J Dermatol 1990, 123(4):453-456.
30. Chen Y.J., Wu C.Y., Shen J.L., et al. Cancer risk in patients with chronic urticaria: a population-based cohort study. Arch Dermatol 2012, 148(1):103-108. 10.1001/archdermatol.2011.682.
31. Ying S., Kikuchi Y., Meng Q., et al. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. JAllergy Clin Immunol 2002, 109(4):694-700.
32. Haas N., Hermes B., Henz B.M. Adhesion molecules and cellular infiltrate: histology of urticaria. JInvestig Dermatol Symp Proc 2001, 6(2):137-138. 10.1046/j.0022-202x.2001.00026.x.
33. Carlson J.A. The histological assessment of cutaneous vasculitis. Histopathology 2010, 56(1):3-23. 10.1111/j.1365-2559.2009.03443.x.
34. Natbony S.F., Phillips M.E., Elias J.M., et al. Histologic studies of chronic idiopathic urticaria. JAllergy Clin Immunol 1983, 71(2):177-183.
35. Claveau J., Lavoie A., Brunet C., et al. Chronic idiopathic urticaria: possible contribution of histamine-releasing factor to pathogenesis. JAllergy Clin Immunol 1993, 92(1 Pt 1):132-137.
36. Kaplan A.P., Horakova Z., Katz S.I. Assessment of tissue fluid histamine levels in patients with urticaria. JAllergy Clin Immunol 1978, 61(6):350-354.
37. Sabroe R.A., Poon E., Orchard G.E., et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. JAllergy Clin Immunol 1999, 103(3 Pt 1):484-493.
38. Hermes B., Prochazka A.K., Haas N., et al. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. JAllergy Clin Immunol 1999, 103(2 Pt 1):307-314.
39. Peters M.S., Winkelmann R.K. Neutrophilic urticaria. Br J Dermatol 1985, 113(1):25-30.
40. Kieffer C., Cribier B., Lipsker D. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine 2009, 88(1):23-31. 10.1097/MD.0b013e3181943f5e.
41. Magen E., Mishal J., Zeldin Y., et al. Clinical and laboratory features of antihistamine-resistant chronic idiopathic urticaria. Allergy Asthma Proc 2011, 32(6):460-466. 10.2500/aap.2011.32.3483.
42. Confino-Cohen R., Aharoni D., Goldberg A., et al. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. JAllergy Clin Immunol 2002, 109(2):349-356.
43. Irinyi B., Aleksza M., Antal-Szalmas P., et al. Cytokine production of CD4+ and CD8+ peripheral T lymphocytes in patients with chronic idiopathic urticaria. Acta Derm Venereol 2002, 82(4):249-253.
44. Piconi S., Trabattoni D., Iemoli E., et al. Immune profiles of patients with chronic idiopathic urticaria. Int Arch Allergy Immunol 2002, 128(1):59-66.
45. Confino-Cohen R., Goldberg A., Aharoni D., et al. Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria. Cytokine 2004, 27(2-3):74-80.
46. Futata E., Azor M., Dos Santos J., et al. Impaired IFN-alpha secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria. Br J Dermatol 2011, 164(6):1271-1279. 10.1111/j.1365-2133.2010.10198.x.
47. Dos Santos J.C., Azor M.H., Nojima V.Y., et al. Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. Int Immunopharmacol 2008, 8(10):1433-1440.
48. Caproni M., Volpi W., Giomi B., et al. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 2004, 84(4):288-290.
49. Kessel A., Yaacoby-Bianu K., Vadasz Z., et al. Elevated serum B-cell activating factor in patients with chronic urticaria. Hum Immunol 2012, 73(6):620-622. 10.1016/j.humimm.2012.03.016.
50. Kasperska-Zajac A., Grzanka A., Czecior E., et al. Acute phase inflammatory markers in patients with non-steroidal anti-inflammatory drugs (NSAIDs)-induced acute urticaria/angioedema and after aspirin challenge. JEur Acad Dermatol Venereol 2012, 10.1111/j.1468-3083.2012.04486.x.
51. Asero R., Tedeschi A., Coppola R., et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. JAllergy Clin Immunol 2007, 119(3):705-710.
52. Vonakis B.M., Saini S.S. New concepts in chronic urticaria. Curr Opin Immunol 2008, 20(6):709-716.
53. Brodell L.A., Beck L.A., Saini S.S. Pathophysiology of chronic urticaria. Ann Allergy Asthma Immunol 2008, 100(4):291-297.
54. O'Donnell B.F., Francis D.M., Swana G.T., et al. Thyroid autoimmunity in chronic urticaria. Br J Dermatol 2005, 153(2):331-335. 10.1111/j.1365-2133.2005.06646.x.
55. O'Donnell B.F., O'Neill C.M., Francis D.M., et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999, 140(5):853-858.
56. Grattan C.E., Wallington T.B., Warin R.P., et al. Aserological mediator in chronic idiopathic urticaria-a clinical, immunological and histological evaluation. Br J Dermatol 1986, 114(5):583-590.
57. Gruber B.L., Baeza M.L., Marchese M.J., et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. JInvest Dermatol 1988, 90(2):213-217.
58. Grattan C.E., Hamon C.G., Cowan M.A., et al. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. Br J Dermatol 1988, 119(2):179-183.
59. Grattan C.E., Boon A.P., Eady R.A., et al. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 1990, 93(2-3):198-204.
60. Guttman-Yassky E., Bergman R., Maor C., et al. The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals. JEur Acad Dermatol Venereol 2007, 21(1):35-39.
61. Grattan C.E., Francis D.M., Hide M., et al. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991, 21(6):695-704.
62. Hide M., Francis D.M., Grattan C.E., et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. NEngl J Med 1993, 328(22):1599-1604.
63. Tong L.J., Balakrishnan G., Kochan J.P., et al. Assessment of autoimmunity in patients with chronic urticaria. JAllergy Clin Immunol 1997, 99(4):461-465.
64. Yasnowsky K.M., Dreskin S.C., Efaw B., et al. Chronic urticaria sera increase basophil CD203c expression. JAllergy Clin Immunol 2006, 117(6):1430-1434.
65. Zweiman B., Valenzano M., Atkins P.C., et al. Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria. JAllergy Clin Immunol 1996, 98(1):89-98.
66. Fusari A., Colangelo C., Bonifazi F., et al. The autologous serum skin test in the follow-up of patients with chronic urticaria. Allergy 2005, 60(2):256-258.
67. Fagiolo U., Kricek F., Ruf C., et al. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. JAllergy Clin Immunol 2000, 106(3):567-572.
68. Niimi N., Francis D.M., Kermani F., et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. JInvest Dermatol 1996, 106(5):1001-1006.
69. Sabroe R.A., Greaves M.W. Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol 2006, 154(5):813-819.
70. Sheikh J. Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they?. Curr Opin Allergy Clin Immunol 2005, 5(5):403-407.
71. Vasagar K., Vonakis B.M., Gober L.M., et al. Evidence of invivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy 2006, 36(6):770-776. 10.1111/j.1365-2222.2006.02494.x.
72. Eckman J.A., Hamilton R.G., Saini S.S. Independent evaluation of a commercial test for "autoimmune" urticaria in normal and chronic urticaria subjects. JInvest Dermatol 2009, 129(6):1584-1586.
73. Cho C.B., Stutes S.A., Altrich M.L., et al. Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders. Ann Allergy Asthma Immunol 2013, 110(1):29-33. 10.1016/j.anai.2012.10.020.
74. Fiebiger E., Hammerschmid F., Stingl G., et al. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. JClin Invest 1998, 101(1):243-251.
75. Kikuchi Y., Kaplan A.P. Mechanisms of autoimmune activation of basophils in chronic urticaria. JAllergy Clin Immunol 2001, 107(6):1056-1062.
76. Soundararajan S., Kikuchi Y., Joseph K., et al. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. JAllergy Clin Immunol 2005, 115(4):815-821.
77. Horn M.P., Pachlopnik J.M., Vogel M., et al. Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies?. FASEB J 2001, 15(12):2268-2274.
78. Horn M.P., Gerster T., Ochensberger B., et al. Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999, 29(4):1139-1148.
79. Eckman J.A., Hamilton R.G., Gober L.M., et al. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. JInvest Dermatol 2008, 128(8):1956-1963. 10.1038/jid.2008.55.
80. Viswanathan R.K., Biagtan M.J., Mathur S.K. The role of autoimmune testing in chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2012, 108(5):337-341.e1. 10.1016/j.anai.2012.02.018.
81. Lapolla W., Desai N., English J.C. Clinical utility of testing for autoimmunity in chronic idiopathic urticaria. JAm Acad Dermatol 2012, 66(3):e83-e88. 10.1016/j.jaad.2010.11.030.
82. Grattan C.E., Francis D.M., Slater N.G., et al. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992, 339(8801):1078-1080.
83. O'Donnell B.F., Barr R.M., Black A.K., et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998, 138(1):101-106.
84. Konstantinou G.N., Asero R., Maurer M., et al. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009, 64(9):1256-1268. 10.1111/j.1398-9995.2009.02132.x.
85. Smith C.H., Kepley C., Schwartz L.B., et al. Mast cell number and phenotype in chronic idiopathic urticaria. JAllergy Clin Immunol 1995, 96(3):360-364.
86. Ferrer M., Nunez-Cordoba J.M., Luquin E., et al. Serum total tryptase levels are increased in patients with active chronic urticaria. Clin Exp Allergy 2010, 10.1111/j.1365-2222.2010.03582.x.
87. Ito Y., Satoh T., Takayama K., et al. Basophil recruitment and activation in inflammatory skin diseases. Allergy 2011, 66(8):1107-1113. 10.1111/j.1398-9995.2011.02570.x.
88. Jacques P., Lavoie A., Bedard P.M., et al. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. JAllergy Clin Immunol 1992, 89(6):1139-1143.
89. Cohen R.W., Rosenstreich D.L. Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. JAllergy Clin Immunol 1986, 77(6):802-807.
90. Saini S.S., Paterniti M., Vasagar K., et al. Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: relationship to expression of Syk and SHIP-2. Clin Immunol 2009, 132(3):342-348. 10.1016/j.clim.2009.05.003.
91. Bossi F., Frossi B., Radillo O., et al. Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation. Allergy 2011, 66(12):1538-1545. 10.1111/j.1398-9995.2011.02704.x.
92. Kaplan A.P., Gray L., Shaff R.E., et al. Invivo studies of mediator release in cold urticaria and cholinergic urticaria. JAllergy Clin Immunol 1975, 55(6):394-402.
93. Kaplan A.P., Garofalo J., Sigler R., et al. Idiopathic cold urticaria: invitro demonstration of histamine release upon challenge of skin biopsies. NEngl J Med 1981, 305:1074-1077.
94. Freichel M., Almering J., Tsvilovskyy V. The role of TRP proteins in mast cells. Frontiers in Immunology 2012, 3:150. 10.3389/fimmu.2012.00150.
95. Ombrello M.J., Remmers E.F., Sun G., et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. NEngl J Med 2012, 366(4):330-338. 10.1056/NEJMoa1102140.
96. Saini S.S. Basophil responsiveness in chronic urticaria. Curr Allergy Asthma Rep 2009, 9(4):286-290.
97. Greaves M.W., Plummer V.M., McLaughlan P., et al. Serum and cell bound IgE in chronic urticaria. Clin Allergy 1974, 4(3):265-271.
98. Kern F., Lichtenstein L.M. Defective histamine release in chronic urticaria. JClin Invest 1976, 57(5):1369-1377.
99. Sabroe R.A., Francis D.M., Barr R.M., et al. Anti-Fc(epsilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. JAllergy Clin Immunol 1998, 102(4 Pt 1):651-658.
100. Luquin E., Kaplan A.P., Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy 2005, 35(4):456-460.
101. Vonakis B.M., Vasagar K., Gibbons S.P., et al. Basophil FceRI histamine release parallels expression of Src-homology2-containing inositol phosphatases in chronic idiopathic urticaria. JAllergy Clin Immunol 2007, 119:441-448.
102. Baker R., Vasagar K., Ohameje N., et al. Basophil histamine release activity and disease severity in chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2008, 100:244-249.
103. Rorsman H. Basophilic leucopenia in different forms of urticaria. Acta Allergol 1962, 17:168-184.
104. Grattan C.E., Walpole D., Francis D.M., et al. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997, 27(12):1417-1424.
105. Caproni M., Volpi W., Macchia D., et al. Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test. Exp Dermatol 2003, 12(5):621-628.
106. Grattan C.E., Dawn G., Gibbs S., et al. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 2003, 33(3):337-341.
107. Wedi B., Raap U., Wieczorek D., et al. Urticaria and infections. Allergy Asthma Clin Immunol 2009, 5(1):10. 10.1186/1710-1492-5-10.
108. Liutu M., Kalimo K., Uksila J., et al. Etiologic aspects of chronic urticaria. Int J Dermatol 1998, 37(7):515-519.
109. Di Campli C., Gasbarrini A., Nucera E., et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998, 43:1226-1229.
110. Baskan E.B., Turker T., Gulten M., et al. Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria. Int J Dermatol 2005, 44(12):993-995.
111. Ertam I., Biyikli S.E., Yazkan F.A., et al. The frequency of nasal carriage in chronic urticaria patients. JEur Acad Dermatol Venereol 2007, 21(6):777-780. 10.1111/j.1468-3083.2006.02083.x.
112. Sharma A.D. Role of nasal carriage of Staphylococcus aureus in chronic urticaria. Indian J Dermatol 2012, 57(3):233-236. 10.4103/0019-5154.96211.
113. Zingale L.C., Beltrami L., Zanichelli A., et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006, 175(9):1065-1070. 10.1503/cmaj.060535.
114. Ozkan M., Oflaz S.B., Kocaman N., et al. Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2007, 99(1):29-33. 10.1016/S1081-1206(10)60617-5.
115. Ben-Shoshan M., Blinderman I., Raz A. Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy 2013, 68(2):131-141. 10.1111/all.12068.
116. Sackesen C., Sekerel B.E., Orhan F., et al. The etiology of different forms of urticaria in childhood. Pediatr Dermatol 2004, 21(2):102-108. 10.1111/j.0736-8046.2004.21202.x.
117. Mortureux P., Leaute-Labreze C., Legrain-Lifermann V., et al. Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol 1998, 134(3):319-323.
118. Plumb J., Norlin C., Young P.C. Exposures and outcomes of children with urticaria seen in a pediatric practice-based research network: a case-control study. Arch Pediatr Adolesc Med 2001, 155(9):1017-1021.
119. Cribier B. Urticaria and hepatitis. Clin Rev Allergy Immunol 2006, 30(1):25-29. 10.1385/CRIAI:30:1:025.
120. Grattan C.E. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003, 28(2):123-127.
121. Palikhe N.S., Sin H.J., Kim S.H., et al. Genetic variability of prostaglandin E2 receptor subtype EP4 gene in aspirin-intolerant chronic urticaria. JHum Genet 2012, 10.1038/jhg.2012.55.